Clinical applications of sequencing take center stage.
Clinical applications of sequencing take center stage.
复制标题
DOI：
10.1186/gb-2013-14-3-303
复制
发表时间：
2013-03-28
期刊：
影响因子：
12.3
通讯作者：
Glusman G
中科院分区：
文献类型：
--
作者：
Glusman G
关于基因组生物学和技术进展（AGBT）会议的报告，美国佛罗里达马可岛，2013年2月20日至23日。今年的基因组生物学与技术进展（AGBT）会议反映了“下一代”测序（NGS）技术的现状：竞争和创新显著减少，并高度关注标准化和应用。显然没有宣布技术突破----这是以前AGBT会议的一个标志----但现有技术继续按照现在预期的指数曲线改进。虽然应用范围广泛，但非常强调临床诊断。
A report on the Advances in Genome Biology and Technology (AGBT) meeting, Marco Island, Florida, USA, February 20-23, 2013. This year's Advances in Genome Biology and Technology (AGBT) meeting reflected the current state of 'next generation' sequencing (NGS) technologies: significantly reduced competition and innovation, and a strong focus on standardization and application. Announcements of technological breakthroughs - a hallmark of previous AGBT meetings - were markedly absent, but existing technologies continued to improve following the now expected exponential curve. Although applications ranged widely, there was a strong emphasis on clinical diagnosis.